Tramadol hydrochloride use and acute deterioration in Parkinson's disease tremor

Movement Disorders

Volumn 24, Issue 4, 2009, Pages 622-623

  Mellor, Katy ^a   Ahmed, Anis ^a   Thomson, Alexander ^a  

^a HOPE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIPARKINSON AGENT; BUPRENORPHINE; CO CARELDOPA; CODEINE; ROPINIROLE; TRAMADOL; UNCLASSIFIED DRUG; NARCOTIC AGENT;

ADL DISABILITY; AGED; BRADYKINESIA; CASE REPORT; DEFECATION HABIT; DISEASE DURATION; DISEASE EXACERBATION; DISEASE SEVERITY; DRUG EFFICACY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; GAIT DISORDER; HUMAN; KNEE PAIN; LETTER; MUSCLE TONE; OSTEOARTHRITIS; PARKINSON DISEASE; PRIORITY JOURNAL; RIGIDITY; TREATMENT DURATION; TREATMENT RESPONSE; TREMOR;

AGED; FEMALE; HUMANS; NARCOTICS; PARKINSON DISEASE; TRAMADOL; TREMOR;

EID: 67651166815     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.22449     Document Type: Letter

References (7)

1. Meylers side effects of drugs: international encyclopedia of adverse drug reactions and interactions, 15th ed. (online). Available at www.sciencedirect.com. Accessed on May 20, 2008.
2. Prescribing information for ULTRAM (tramadol). Revised February 2007. Manufactured by Janssen Ortho, LLC. Available at https:www.ortho-mcneil.com/ortho-mcneil/shared/pi/ultram.pdf. Accessed online on August 23, 2008.
3. Gleason P, Frye R, O'Toole T. Debilitating reaction following the initial dose of tramadol. Ann Pharmacother 1997;31:1150-1152.
4. Iglesias GC, Gonzalez II, Naves GC, Alonso VMJ. Acute psychotic disorder and movement disorder after tramadol clorhidrate plus hioscine N-butilbromure treatment. Anales de Psiquiatria 200622:0213-0599.
5. Scholtissen B, Verhey FRJ, Steinbusch HWM, Leentjens AFG. Serotonergic mechanisms in Parkinson's disease: opposing results from preclinical and clinical data. J Neural Transm 2006;113:59-73.
6. De Deuerwaerdere P, Navailles S, Berg KA, Clarke WP, Spampinato U. Constitutive activity of the serotonin 2C receptor inhibits in vivo dopamine release in the rat striatum and nucleus accumbens. J Neurosci 2004;24:3235-3241.
7. Benloucif S, Keegan MJ, Galloway MP. Serotonin-facilitated dopamine release in vivo: pharmacological characterization. J Pharmacol Exp Therapy 1993;265:373-377.